Idiopathic pulmonary fibrosis (IPF), an incurable health condition, affects the quality of life of millions of people all over the globe. While the progression of the disease is unpredictable and the cause often unknown, patients can still achieve better quality of life through effective care planning, which involves managing symptoms and monitoring the disease.
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Effective Care Planning: A Better Quality of Life Despite IPF
1. [BRAND LOGO]
+ [INSERT IMAGE HERE][INSERT IMAGE HERE]
Life Relay Health Care Solutions Inc.
1111 Haro St. Suite 802
Vancouver, BC, Canada
V6E 1E3
1-888-488-9965
Effective Care Planning:
A Better Quality of Life
Despite IPF
2. [BRAND LOGO]
+Effective Care Planning: A Better Quality of Life Despite IPF
Managing Symptoms
One of the most effective therapies encouraged by doctors to IPF patients is pulmonary
rehabilitation. This therapy combines physical activities and health information. Patients are
able to improve physical skills through active engagement with routine activities. They also
learn about better management of IPF symptoms with nutritional guidance, emotional
support, and breathing technique training from health practitioners.
Idiopathic pulmonary fibrosis (IPF), an incurable health
condition, affects the quality of life of millions of
people all over the globe. While the progression of the
disease is unpredictable and the cause often unknown,
patients can still achieve better quality of life through
effective care planning, which involves managing
symptoms and monitoring the disease.
3. [BRAND LOGO]
+o experienced a reduction of at least 10% in breathing ability.
Monitoring the Disease
Monitoring is crucial in slowing down the progression of disease. Knowing the pace of
the decline will allow physicians to evaluate the effectiveness of therapies and
suggest potential treatments. Doctors recommend monitoring every 3 to 6 months.
One of the methods used by health practitioners is spirometry. This procedure
evaluates how much and how quickly patients can release air out of the lungs. Doctors
look into the following metrics: forced vital capacity (FVC), forced expiratory volume
1 (FEV1) and total lung capacity (TLC).
Diffusing capacity test is
also an effective method in
observing the progression of
IPF. The test allows doctors
to determine how well the
lungs exchange oxygen for
carbon dioxide.
Idiopathic pulmonary
fibrosis (IPF) may be an
incurable disease, but
achieving a better quality
of life is still possible. The key is in effective care planning, which includes managing
symptoms and monitoring the disease.